Symmetry Medical Inc.’s (NYSE:SMA - News) share price has entered into oversold territory with a stochastic value of 18.432. The Zacks Consensus Estimate on the company’s earnings for December 2012 increased by 3 cents over the past two months to 52 cents per share. Symmetry Medical Inc is a Zacks #2 Rank (“Buy”) company.
SYMMETRY MED INC (SMA): Free Stock Analysis Report
More From Zacks.com



There are no comments yet